Antimetabolite Immunosuppressant [EPC]

21363 reported adverse events

Drugs of this class: MYCOPHENILIC ACID

These side effects are most commonly reported by patients taking drugs of the Antimetabolite Immunosuppressant [EPC] class:

# Side effect Count
0 OFF LABEL USE 2300
1 DRUG INEFFECTIVE 1556
2 DIARRHOEA 1110
3 ACUTE KIDNEY INJURY 922
4 COVID-19 805
5 NAUSEA 803
6 PRODUCT USE IN UNAPPROVED INDICATION 773
7 PYREXIA 766
8 DRUG INTERACTION 736
9 DEATH 723
See all common reactions for Antimetabolite Immunosuppressant [EPC]

Drugs of the Antimetabolite Immunosuppressant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALACOPLAKIA 103 0.2249
1 CENTRAL NERVOUS SYSTEM LUPUS 43 0.1928
2 HEART FAILURE WITH PRESERVED EJECTION FRACTION 49 0.1667
3 CEREBRAL NOCARDIOSIS 37 0.1588
4 BODY MASS INDEX ABNORMAL 38 0.1557
5 DISSEMINATED MUCORMYCOSIS 52 0.1320
6 MONKEYPOX 36 0.1304
7 APOPTOSIS 40 0.1294
8 PULMONARY NOCARDIOSIS 104 0.1262
9 AMAUROSIS FUGAX 134 0.1244
See all enriched reactions for Antimetabolite Immunosuppressant [EPC]